Literature DB >> 8996135

Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery.

D Caillot1, O Casasnovas, A Bernard, J F Couaillier, C Durand, B Cuisenier, E Solary, F Piard, T Petrella, A Bonnin, G Couillault, M Dumas, H Guy.   

Abstract

PURPOSE: The prognosis of invasive pulmonary aspergillosis (IPA) occurring in neutropenic patients remains poor. We studied whether new strategies for early diagnosis could improve outcome in these patients. PATIENTS AND METHODS: Twenty-three histologically proven and 14 highly probable IPAs in 37 hematologic patients (neutropenic in 36) were analyzed retrospectively.
RESULTS: The most frequent clinical signs associated with IPA were cough (92%), chest pain (76%), and hemoptysis (54%). Bronchoalveolar lavage (BAL) was positive in 22 of 32 cases. Aspergillus antigen test was positive in 83% of cases when tested on BAL fluid. Since October 1991, early thoracic computed tomographic (CT) scans were systematically performed in febrile neutropenic patients with pulmonary x-ray infiltrates. This approach allowed us to recognize suggestive CT halo signs in 92% of patients, compared with 13% before this date, and the mean time to IPA diagnosis was reduced dramatically from 7 to 1.9 days. Among 36 assessable patients, 10 failed to respond (amphotericin B [AmB] plus fluorocytosyne, n = 2; itraconazole + AmB, n = 8) and died of aspergillosis. Twenty-six patients were cured or improved by antifungal treatment (itraconazole with or without AmB, n = 22; voriconazole, n = 4). In 15 of 16 cases, surgical resection was combined successfully with medical treatment. Achievement of hematologic response, early diagnosis, unilateral pulmonary involvement, and highest level of fibrinogen value < 9 g/L were associated with better outcome.
CONCLUSION: In febrile neutropenic patients, systematic CT scan allows earlier diagnosis of IPA. Early antifungal treatment, combined with surgical resection if necessary, improves IPA prognosis dramatically in these patients.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8996135     DOI: 10.1200/JCO.1997.15.1.139

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  87 in total

Review 1.  A persistent challenge: the diagnosis of respiratory disease in the non-AIDS immunocompromised host.

Authors:  C Mayaud; J Cadranel
Journal:  Thorax       Date:  2000-06       Impact factor: 9.139

2.  Aspergillus antigen testing in bone marrow transplant recipients.

Authors:  E C Williamson; D A Oliver; E M Johnson; A B Foot; D I Marks; D W Warnock
Journal:  J Clin Pathol       Date:  2000-05       Impact factor: 3.411

3.  Prospective comparison of the diagnostic potential of real-time PCR, double-sandwich enzyme-linked immunosorbent assay for galactomannan, and a (1-->3)-beta-D-glucan test in weekly screening for invasive aspergillosis in patients with hematological disorders.

Authors:  Masahito Kawazu; Yoshinobu Kanda; Yasuhito Nannya; Katsunori Aoki; Mineo Kurokawa; Shigeru Chiba; Toru Motokura; Hisamaru Hirai; Seishi Ogawa
Journal:  J Clin Microbiol       Date:  2004-06       Impact factor: 5.948

Review 4.  Antifungal agents: in vitro susceptibility testing, pharmacodynamics, and prospects for combination therapy.

Authors:  A H Groll; H Kolve
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-03-11       Impact factor: 3.267

Review 5.  Pulmonary aspergillosis: clinical presentation, diagnostic tests, management and complications.

Authors:  Rami Sherif; Brahm H Segal
Journal:  Curr Opin Pulm Med       Date:  2010-05       Impact factor: 3.155

6.  Diagnosis and antimicrobial therapy of lung infiltrates in febrile neutropenic cancer patients.

Authors:  Georg Maschmeyer
Journal:  Curr Infect Dis Rep       Date:  2011-12       Impact factor: 3.725

7.  Quick and reliable galactomannan detection in crude minced lung specimens from haematological patients with suspected invasive fungal infection: results from a case series.

Authors:  D D'Antonio; A Manna; V Savini; D Onofrillo; G Di Bonaventura; R Piccolomini; G Parruti
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-03-04       Impact factor: 3.267

8.  Assessment of serum (1->3)-beta-D-glucan concentration as a measure of disease burden in a murine model of invasive pulmonary aspergillosis.

Authors:  Nathan P Wiederhold; Laura K Najvar; Ana C Vallor; William R Kirkpatrick; Rosie Bocanegra; Destiny Molina; Marcos Olivo; John R Graybill; Thomas F Patterson
Journal:  Antimicrob Agents Chemother       Date:  2007-12-26       Impact factor: 5.191

9.  Development of a LightCycler PCR assay for detection and quantification of Aspergillus fumigatus DNA in clinical samples from neutropenic patients.

Authors:  Birgit Spiess; Dieter Buchheidt; Corinna Baust; Heyko Skladny; Wolfgang Seifarth; Udo Zeilfelder; Christine Leib-Mösch; Handan Mörz; Rüdiger Hehlmann
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

10.  Rapid differentiation of Aspergillus species from other medically important opportunistic molds and yeasts by PCR-enzyme immunoassay.

Authors:  Liliana de Aguirre; Steven F Hurst; Jong Soo Choi; Jong Hee Shin; Hans Peter Hinrikson; Christine J Morrison
Journal:  J Clin Microbiol       Date:  2004-08       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.